A New Way Out of the Predicament of Anaplastic Thyroid Carcinoma From Existing Data Analysis

BackgroundAnaplastic thyroid carcinoma (ATC) is an endocrine tumor with a low incidence but a very poor prognosis. The vast majority of patients have a survival time of only three to six months, but a few survive for two years or more. In recent years, there have been major breakthroughs in targeted...

Full description

Bibliographic Details
Main Authors: Yikun Zhou, Yang Zhao, Xi Ding, Jing Liang, Huayang Xu, Yuxuan Lin, Hamad Haider Khan, Bingyin Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.887906/full